Table 1.
HIV negative | HIV positive | HIV unknown | |
n (%) | n (%) | n (%) | |
Age | |||
Median age (IQR) (years) | 18 (13–21) | 22 (19–23) | 20 (16–22) |
10–14 | 635 (32.3%) | 200 (10.8%) | 922 (19.8%) |
15–19 | 585 (29.8%) | 338 (18.2%) | 1331 (28.6%) |
20–24 | 744 (37.9%) | 1317 (71.0%) | 2407 (51.7%) |
Sex | |||
Female | 877 (44.7%) | 1247 (67.2%) | 2484 (53.3%) |
Male | 1087 (55.3%) | 607 (32.7%) | 2169 (46.5%) |
Missing | 0 (0%) | 1 (0.1%) | 7 (0.2%) |
Ethnicity | |||
Asian | 34 (1.7%) | 14 (0.8%) | 106 (2.3%) |
Black | 1258 (64.1%) | 1593 (85.9%) | 3525 (75.6%) |
Coloured (mixed race) | 323 (16.4%) | 103 (5.6%) | 317 (6.8%) |
White | 274 (14.0%) | 74 (4.0%) | 487 (10.5%) |
Missing | 75 (3.8%) | 71 (3.8%) | 225 (4.8%) |
Type of cancer | |||
Non-AIDS defining cancer | 1699 (86.5%) | 697 (37.6%) | 3411 (73.2%) |
AIDS defining cancer | 206 (10.5%) | 1129 (60.9%) | 1062 (22.8%) |
Primary site unknown | 59 (3.0%) | 29 (1.6%) | 187 (4.0%) |
ART calendar period | |||
2004–2007 | 594 (30.2%) | 500 (27.0%) | 2062 (44.2%) |
2008–2011 | 822 (41.9%) | 784 (42.3%) | 1647 (35.3%) |
2012–2014 | 548 (27.9%) | 571 (30.8%) | 951 (20.4%) |
Multiple primary cancer | |||
Yes | 10 (0.50%) | 13 (0.70%) | 31 (0.67%) |
No | 1954 (99.5%) | 1842 (99.3%) | 4629 (99.3%) |
Total | 1964 (100%) | 1855 (100%) | 4660 (100%) |
Multiple primary cancer refers to an individual with more than one cancer at different primary sites.
ART, antiretroviral therapy; IQR, interquartile range.